News GH Research PLC

Equities

GHRS

IE000GID8VI0

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
12.07 ^USD	-1.39%		-14.34%	+108.10%

May. 03	GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 01	JMP Securities Cuts Price Target on GH Research to $39 From $50, Maintains Market Outperform Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GH Research : Notice of Annual General Meeting to be held on 27 June 2024 - Form 6-K	May. 15	PU
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates	May. 03	AQ
GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 03	CI
JMP Securities Cuts Price Target on GH Research to $39 From $50, Maintains Market Outperform Rating	Mar. 01	MT
GH Research PLC Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates	Feb. 29	AQ
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression	Jan. 18	AQ
Stifel Adjusts Price Target on GH Research to $18 From $25, Maintains Buy Rating	Dec. 18	MT
HC Wainwright Cuts GH Research's Price Target to $40 From $45, Maintains Buy Rating	Nov. 14	MT
GH Research PLC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
GH Research Reports Third Quarter Financial Results and Provides Business Updates	Nov. 09	AQ
GH Research : Corporate Presentation	Nov. 08	PU
GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression	23-09-29	AQ
GH Research PLC Provides Updates and Guidance on Its Clinical Development Program for GH001 in Treatment-Resistant Depression	23-09-29	CI
GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates	23-08-23	AQ
GH Research PLC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-23	CI
GH Research : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION - Form 6-K	23-07-19	PU
Gh Research plc Announces Accepted for Publication in Frontiers in Psychiatry	23-05-25	CI
JMP Securities Adjusts Price Target on GH Research to $49 From $46, Maintains Market Outperform Rating	23-05-12	MT
GH Research : Unaudited condensed consolidated interim statement of comprehensive income - Form 6-K	23-05-11	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GH Research PLC

Equities

GHRS

IE000GID8VI0

Summary

Filters